Loading data for BMGL — first visit, this takes a few seconds.
Basel Medical Group Ltd (BMGL)
NasdaqCM: BMGL
· Echtzeitkurs · USD
5.26
+0.37 (7.57%)
Zum Schluss: Aug 18, 2026, 8:00 PM
5.50
+5.77%
Vorbörslich: 5:29 AM
Basel Medical Group Ltd (BMGL) Stock Price, Analysis & Data
7.57% (1D)
Keine Daten verfügbar
| Geld | 3.25 |
| Marktkapitalisierung | 8.14 Mio |
| Umsatz (TTM) | 14.74 Mio |
| Nettogewinn (TTM) | -10.05 Mio |
| Beta | n/a |
| EPS (ttm) | -5.72 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 1.66 |
| KUV (TTM) | 0.55 |
| Earnings Date | n/a |
| Brief | 6.06 |
| Volumen | 37,792 |
| Ø Vol. (20D) | 62,778 |
| Eröffnung | 4.86 |
| Vortagesschluss | 4.89 |
| Tagesspanne | 4.50 - 5.49 |
| 52-Wk Range | 4.17 - 25.80 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über BMGL
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services...
Branche Medical Care Facilities
Sektor Healthcare
IPO Datum Feb 25, 2025
Mitarbeiter 82
Börse NasdaqCM
Tickersymbol BMGL
Website https://baselmedical.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Basel Medical Ltd 11.32 Mio, ein Anstieg von 12.63% im Vergleich zum Vorjahr (10.05 Mio). Der Gewinn lag bei -10.64 Mio, ein Rückgang von -613.11 %.
Finanzberichte